Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiogenesis Inhibitors in NSCLC.
Manzo A, Montanino A, Carillio G, Costanzo R, Sandomenico C, Normanno N, Piccirillo MC, Daniele G, Perrone F, Rocco G, Morabito A. Manzo A, et al. Among authors: sandomenico c. Int J Mol Sci. 2017 Sep 21;18(10):2021. doi: 10.3390/ijms18102021. Int J Mol Sci. 2017. PMID: 28934120 Free PMC article. Review.
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.
De Luca A, Selvam MP, Sandomenico C, Pepe S, Bianco AR, Ciardiello F, Salomon DS, Normanno N. De Luca A, et al. Among authors: sandomenico c. Int J Cancer. 1997 Oct 9;73(2):277-82. doi: 10.1002/(sici)1097-0215(19971009)73:2<277::aid-ijc19>3.0.co;2-c. Int J Cancer. 1997. PMID: 9335455 Free article.
Vandetanib: An overview of its clinical development in NSCLC and other tumors.
Morabito A, Piccirillo MC, Costanzo R, Sandomenico C, Carillio G, Daniele G, Giordano P, Bryce J, Carotenuto P, La Rocca A, Di Maio M, Normanno N, Rocco G, Perrone F. Morabito A, et al. Among authors: sandomenico c. Drugs Today (Barc). 2010 Sep;46(9):683-98. doi: 10.1358/dot.2010.46.9.1516989. Drugs Today (Barc). 2010. PMID: 20967300 Review.
Gefitinib in non small cell lung cancer.
Costanzo R, Piccirillo MC, Sandomenico C, Carillio G, Montanino A, Daniele G, Giordano P, Bryce J, De Feo G, Di Maio M, Rocco G, Normanno N, Perrone F, Morabito A. Costanzo R, et al. Among authors: sandomenico c. J Biomed Biotechnol. 2011;2011:815269. doi: 10.1155/2011/815269. Epub 2011 May 23. J Biomed Biotechnol. 2011. PMID: 21660144 Free PMC article. Review.
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Di Maio M, Signoriello S, Morabito A, Rossi A, Maione P, Piantedosi F, Bilancia D, Cigolari S, Barbera S, Gebbia V, Daniele B, Robbiati SF, Illiano A, Ceribelli A, Carrozza F, Favaretto A, Piazza E, Piccirillo MC, Daniele G, Giordano P, Costanzo R, Sandomenico C, Rocco G, Gallo C, Perrone F, Gridelli C. Di Maio M, et al. Among authors: sandomenico c. Lung Cancer. 2012 Jun;76(3):457-64. doi: 10.1016/j.lungcan.2012.01.002. Epub 2012 Jan 31. Lung Cancer. 2012. PMID: 22297086
Cetuximab in non-small-cell lung cancer.
Carillio G, Montanino A, Costanzo R, Sandomenico C, Piccirillo MC, Di Maio M, Daniele G, Giordano P, Bryce J, Normanno N, Rocco G, Perrone F, Morabito A. Carillio G, et al. Among authors: sandomenico c. Expert Rev Anticancer Ther. 2012 Feb;12(2):163-75. doi: 10.1586/era.11.178. Expert Rev Anticancer Ther. 2012. PMID: 22316364 Review.
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
Morabito A, Gebbia V, Di Maio M, Cinieri S, Viganò MG, Bianco R, Barbera S, Cavanna L, De Marinis F, Montesarchio V, Costanzo R, Sandomenico C, Montanino A, Mancuso G, Russo P, Nacci A, Giordano P, Daniele G, Piccirillo MC, Rocco G, Gridelli C, Gallo C, Perrone F. Morabito A, et al. Among authors: sandomenico c. Lung Cancer. 2013 Jul;81(1):77-83. doi: 10.1016/j.lungcan.2013.04.008. Epub 2013 May 1. Lung Cancer. 2013. PMID: 23643177 Clinical Trial.
78 results